Without definitive treatment, mortality from severe aplastic anemia (AA) approaches 70% at 2 years. Establishing an accurate etiology of the AA is challenging but also absolutely critical to appropriate management, especially differentiating between acquired and inherited forms of the disease. This review emphasizes the newer data on molecular (somatic and germline) findings in AA and how they are (or are not) helpful during diagnosis.

According to Daniel A. Nation, PhD, associate professor of psychological science at University of California, Irvine: “Studies of angiotensin II receptor blockers and ACE inhibitors have suggested these medicines may confer the greatest benefit to long-term cognition, while other studies have shown the benefits of calcium channel blockers and diuretics on reducing dementia risk.”

The results of the International Ivermectin Project Team were finally published this week in Open Forum Infectious Diseases, and although they’re positive, they haven’t escaped criticism, and most researchers still want results from a randomized controlled trial. In addition, many studies included in the analysis were not peer reviewed, which was a limitation, and studies varied widely in terms of dosage, treatment duration, and inclusion criteria.

Medical jargon and the complexity of medical information may cause misunderstandings and patient discomfort when bedside case presentations are taking place. To see if outside-the-room case presentations were more effective, the researchers examined the patients’ average knowledge of three dimensions of their medical care in both settings — understanding their disease, the therapeutic approach being used, and further plans for care.

An extremely interesting case in New York is examined in this article, which chronicles a female patient suffering from multiple sclerosis and her suit against her neurologist for prescribing a new medication that her attorney feels goes beyond medical malpractice and into fraud under NY’s General Business Law 349: “deceptive acts or practices in the conduct of any business, trade or commerce or in the furnishing of any service in this state are hereby declared unlawful.”

There are several reasons why the COVID-19 Delta variant – responsible for the COVID crisis in India – has public health experts and doctors concerned, including its transmissibility and disease severity. You likely already know the Delta “variant of concern” is more contagious than previous variants (denoted by the Greek alphabet), but here are five other important details you should be aware of.